Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000539989 | SCV000652069 | benign | Cutis laxa, autosomal recessive, type 1B | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697378 | SCV000717477 | likely benign | not provided | 2021-06-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27535533) |
Ambry Genetics | RCV002384231 | SCV002673577 | benign | Cardiovascular phenotype | 2020-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330792 | SCV004039363 | likely benign | not specified | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003952836 | SCV004769614 | likely benign | EFEMP2-related disorder | 2019-04-11 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |